This is an aggregated industry headline. Read the full story at Pharmaceutical Technology →
Bayer banks €3bn in Apollo contraceptives division deal
Bayer's agreement with Apollo comes a little after Bayer broke its pharma dealmaking fast by acquiring Perfuse Therapeutics in May 2026.
By Pharmaceutical Technology
· Jul 10, 2026
· via Pharmaceutical Technology
Image: Pharmaceutical Technology
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlinePharmaceutical Technology
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Bayer has addressed its need for a capital infusion under a deal to secure 3 billion euros ($3.4 billion) in e…
The WeekFierceBiotech ↗
KKR, the global investment giant, has launched Allyntra as a new, precision-engineered solutions platform for …
The WeekBriefing
The FDA has expanded the use of the Padcev-Keytruda combination in bladder cancer, intensifying competition fo…